Back to search

France· FR:65255066

PIRFENIDONE BIOGARAN 267 mg, comprimé pelliculé

A pirfenidone product containing pirfénidone, registered in France by BIOGARAN, on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC L04AX05

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedPIRFENIDONE BIOGARAN 267 mg, comprimé…ATCL04AX05REGISTER NO.FR:65255066PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Pirfenidone is registered in 17 of 19 countries.

Countries holding a registration under ATC L04AX05 (pirfenidone), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 9 of them publish a price we can compare per daily dose

Pirfenidone · ATC L04AX05

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of pirfenidone costs, country by country.

Normalised to the WHO defined daily dose (2.4 g), the median price runs from $27.36 in France to $63.67 in Switzerland — a ×2.3 gap.

  • France: $27.36 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Pirfenidone · price per daily dose (2.4 g)

USD · FX 28 Sept 2026

  • CH Switzerland$63.67
  • FR France$27.36
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
PIRFÉNIDONE
Manufacturer
BIOGARAN
Country
France (FR)
ATC code
L04AX05
ATC class
Pirfenidone
Defined daily dose
2.4 g, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930256756
    plaquette(s) PVC aluminium de 252 comprimé(s)
    EUR 673.67

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

132 interactions on record for pirfenidone.

Graded by severity as the source publishes them — 20 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Pirfenidone · interactions on record

132 records

  • 20 severe
  • 110 moderate
  • 2 minor

Most severe, free to view

  • GivosiranA16AX16severe
  • AmiodaroneC01BD01severe
  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pirfenidone in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pirfenidone products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Pirfenidon Accord, Pirfenidon Actavis
  • Belgium · Perfenidon Eg, Pirfenidon Cipla
  • Bulgaria · Fredalix
  • Cyprus · Pirfenidone Accord, Pirfenidone Msn
  • Czechia · Fredalix, Pirfenidon Zentiva
  • Germany · Equitor, Pirfenair
  • Denmark · Fredalix, Pirfenair
  • Estonia · Pirfenidone Accord, Pirfenidone Msn
  • Spain · Pirfenidona Accord, Pirfenidona Aurovitas
  • Finland · Pirfenidon Cipla, Pirfenidone Accord
  • United Kingdom (Northern Ireland) · Pirfenidon Msn Laboratories Europe, Pirfenidone
  • Greece · Orepir, Pirfenidone Accord
  • Croatia · Pirfenidon Accord, Pirfenidon Sandoz
  • Hungary · Pirfenidon Zentiva
  • Ireland · Pirfenidone Accord, Pirfenidone Axunio
  • Iceland · Esbriet, Pirfenidon Medical Valley
  • Italy · Blamonehel, Pirfenidone Accord
  • Liechtenstein · Esbriet, Pirfenidone Viatris
  • Lithuania · Pirfenidone Accord, Pirfenidone Msn
  • Luxembourg · Pirfenidon Eg
  • Latvia · Pirfenidone Accord, Pirfenidone Msn
  • Malta · Pirfenidone Clonmel, Pirfenidone Msn
  • Netherlands · Pirfenidon Accord, Pirfenidon Amarox
  • Norway · Esbriet, Pirfenidon Cipla
  • Poland · Pirfenidon Cipla Europe, Pirfenidon Medical Valley
  • Portugal · Pirfenidona Accord, Pirfenidona Generis
  • Romania · Pirfenidon Msn
  • Sweden · Pirfenidon Cipla, Pirfenidon Medical Valley
  • Slovenia · Pirfenidon Accord, Pirfenidon Teva
  • Slovakia · Pirfenidón Accord, Pirfenidone Msn

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f56754ee-3ac9-4a6d-aec3-329ed1871f05
GET /v1/drugs/f56754ee-3ac9-4a6d-aec3-329ed1871f05?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "65255066",
  "date_amm": "2022-07-04",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "PIRFÉNIDONE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé pelliculé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about pirfenidone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.